Tara Bancroft, Ph.D.

Tara Bancroft, Ph.D. is a Vice President and senior equity research analyst on the biotechnology team at TD Cowen. Dr. Bancroft has over five years of equity research experience covering large-, mid-, and small-cap biotechnology stocks.

Prior to joining TD Cowen, Dr. Bancroft was an AVP at Piper Sandler (previously Piper Jaffray) for three years. Prior to Piper Sandler, Dr. Bancroft spent over four years as a postdoctoral researcher first at the La Jolla Institute for Immunology in San Diego where she identified optimized antigen epitopes for a re-formulated pertussis vaccine that went on to be published in Cellular Immunology and others. She then completed a postdoc at Fred Hutch in Seattle, where she discovered B-cell precursors to protective anti-HIV antibodies for the purpose of HIV vaccine design (which was published in JEM and others).

She received her Ph.D. from Yale University where she focused on discovering novel mechanisms involved in vascular injury and inflammation, resulting in numerous primary publications. She also completed a BS in biology at SUNY Buffalo, where she worked full-time in an oncology lab (with published work in JCP) and at an HIV clinical trial center.